Cost-effective pharmaceutical testing equipment will be a new direction for pharmaceutical machine industry

Since the beginning of the 21st century, the demand for test instruments has begun to grow at a relatively high rate. With the formulation of the national standards system for drug safety and the introduction in the future, the drug safety testing industry will face tremendous opportunities for development, and the market for testing equipment will also expand indefinitely. 

The world-class packaging and printing companies are accelerating their development in China with absolute control, the establishment of wholly-owned manufacturing companies and holding companies, mergers and acquisitions of China's dominant companies, etc., and they have brought new ideological awareness. Domestic packaging companies are aware of the crisis and huge Opportunities, spare no effort to improve the competitiveness of their own companies through various means, many companies have realized that product quality is the life of an enterprise and an important guarantee for the survival and development of an enterprise.

The quality of products has been valued by more and more companies. One of the important links in improving product quality is quality inspection, and inspections by quality inspection departments on a regular basis. It does not fundamentally solve quality problems, and inspection costs are expensive. Therefore, a considerable number of companies set up their own quality inspection departments, purchase inspection equipment, and conduct self-checks anytime anywhere. The demand for experimental instruments has entered a period of rapid development.

The pharmaceutical intermediate market has also seen more new demands. Some companies that use packaging materials have also continuously added quality inspection equipment to check and test the materials sent by the manufacturers one by one. Whether each batch meets the requirements, this undoubtedly puts higher requirements on the manufacturers. Pharmaceutical companies like Hunan Jiuzhitang, Chengde Neck Back, and Jiangsu Sihuan have all purchased package quality inspection equipment to check on raw materials and ensure the shelf life of pharmaceuticals after they leave the factory.

Therefore, pharmaceutical companies must continue to invest in R&D and put professional, serial, and cost-effective instruments into the market, making it possible for test instruments to grow at a relatively high speed. At the same time, we must also increase the competitiveness of pharmaceutical testing equipment and break the monopoly of foreign equipment.